|
23 Mar 2025 |
Bajaj Consumer Care
|
Consensus Share Price Target
|
164.07 |
232.25 |
- |
41.56 |
buy
|
|
|
|
|
25 Apr 2017
|
Bajaj Consumer Care
|
Karvy
|
164.07
|
426.00
|
403.45
(-59.33%)
|
Target met |
Hold
|
|
|
Managed to Post Flat Revenue Numbers YoY Due to De-growth in Volume Numbers: Bajaj Corp has delivered flat revenue numbers for the year due to 3.2% de-growthin volumes which is mainly due to destocking continued in the wholesale segment as well as the sluggish revival in the rural markets. EBITDA for the year reported at Rs. 2636 Mn which is declined by 3.7% over the last year. The company has reported total income from operations at Rs.2045 Mn during this quarter,registering 2.0% YoY de-growth, compared to Rs.2088 Mn during Q4FY16.
|
|
17 Apr 2017
|
Bajaj Consumer Care
|
Reliance Securities
|
164.07
|
463.00
|
401.95
(-59.18%)
|
Target met |
Buy
|
|
|
Bajaj Corp has delivered poor set of numbers in 4QFY17 with its net sales falling by 1.9% YoY to Rs2bn, while pre-exceptional net profit plummeted by 20.2% YoY to Rs527mn. Overall volume for the quarter has declined by 7% YoY. Considering the tough quarter, we have revised our revenue and profit estimate for FY18E downwards by 4% and 7%, respectively. We expect Bajaj Corp to report revenue and earnings CAGR of 14.5% and 18.5%, respectively through FY17-19E. Considering the Company's market leadership and pricing power, coupled with attractive...
|
|
14 Mar 2017
|
Bajaj Consumer Care
|
Rudra Shares and Stock Brokers Ltd
|
164.07
|
440.00
|
368.00
(-55.42%)
|
Target met |
Buy
|
|
|
No mark registered net sales of around ` 5.3 crore sales in Dec'16 quarter. The business is improving, but new products planned will be launched only in April'17 onwards. Company testing out the new strategy of focusing on No Marks Cream in one state at a time, the results of which will be known in a couple of month's time. So, if the results turn out to be positive sometime in...
|
|
13 Jan 2017
|
Bajaj Consumer Care
|
Reliance Securities
|
164.07
|
481.00
|
384.10
(-57.28%)
|
Target met |
Buy
|
|
|
In the light of demonetisation and its resultant impact on consumer demand, Bajaj Corp has reported decent numbers in 3QFY17. Its net sales fell by 4.8% yoy to Rs1.9bn, while net profit grew by 17.2% yoy to Rs578mn aided by favourable base that included amortisation charge of Nomarks. We expect recovery in demand in FY18E owing to improved consumer sentiments and higher currency circulation. Expecting 9.1% & 21% CAGR in revenue and earnings through FY16-18E, we reiterate our BUY...
|
|
26 Oct 2016
|
Bajaj Consumer Care
|
CD Equisearch
|
164.07
|
447.00
|
400.00
(-58.98%)
|
Target met |
Accumulate
|
|
|
in volumes and value respectively. On the other hand, light hair oil exhibited a growth of 0.2% and 1.2% in volumes and value respectively, over the same time period, with Almond Drops hair oil displaying a de growth of 1.5% and...
|
|
19 Oct 2016
|
Bajaj Consumer Care
|
Karvy
|
164.07
|
469.00
|
406.00
(-59.59%)
|
|
Buy
|
|
|
PAT Margins Expanded; but Muted Pick-up in ADHO Volume Numbers: Bajaj Corp has delivered flat growth numbers in Q2FY17 under sluggish demand scenario. The companys flagship brand Almond Drops Hair Oil (ADHO) has shownslight drop in volume and value due to adverse demand effect. The company has reported total income from operations at Rs.1968 Mn during this quarter, postingYoY growth of 3.5% when compared to Rs.1901 Mn during Q2FY16.
|
|
27 Jul 2016
|
Bajaj Consumer Care
|
Phillip Capital
|
164.07
|
450.00
|
395.00
(-58.46%)
|
Target met |
Buy
|
|
|
Revenue growth was in line with their expectations; affected by slowdown in rural markets and sluggish demand in urban markets .Flagship brand Bajaj Almond Drops saw volume growth of 1% vs. our expectation of 2%. NoMarks sales fell 16% as ongoing repositioning of the brand has not met with success.Margins continued to expand led by further fall in prices of key raw material – LLP PAT growth was in line with our expectations.Phillip Capital value Bajaj Corp at 23x FY18 EPS (22x earlier) at Rs 450 (Rs 440 earlier). While target multiple is at a substantial discount of 40% to the sector’s target multiple due to the Bajaj Corp's limited diversification, maintain Buy on upside potential and valuation comfort.
Trendlyne has 7 reports on BAJAJCORP updated in the last year from 4 brokers with an average target of Rs 463.3. Brokers have a rating for BAJAJCORP with 1 price downgrade,1 price upgrade in past 6 months and 2 price downgrades,2 price upgrades in past 1 Year.
|
|
26 Jul 2016
|
Bajaj Consumer Care
|
Reliance Securities
|
164.07
|
480.00
|
399.05
(-58.88%)
|
|
Buy
|
|
|
Bajaj Corp's revenue grew by 1.8% yoy to Rs2bn, while net profit rose by 10.1% to Rs522mn and EBITDA stood at Rs709mn in 1QFY17. Overall volume growth stood at 0.8%, while flagship Almond Drops Hair Oil (ADHO) witnessed 2.2% volume growth during the quarter. We expect Bajaj Corp to report 15% CAGR in revenues and 24.9% CAGR in earnings through FY16-18E and maintain our BUY...
|
|
15 Apr 2016
|
Bajaj Consumer Care
|
Phillip Capital
|
164.07
|
440.00
|
399.35
(-58.92%)
|
Target met |
Buy
|
|
|
Revenue growth (value and volume) was below our and consensus expectations due to slowdown in rural markets and high base in Q4FY15. Flagship brand Bajaj Almond Drops saw primary volumes decline by 4% yoy while...
|
|
13 Apr 2016
|
Bajaj Consumer Care
|
Reliance Securities
|
164.07
|
480.00
|
396.35
(-58.60%)
|
|
Buy
|
|
|
Bajaj Corp's 4QFY16 numbers were below our expectations on all fronts. Net sales for the quarter fell by 3.2% to Rs2.3bn vs. our estimate of Rs2.5bn. Net profits too came in lower at Rs540mn as against our estimates of Rs649mn. The company reported overall volume drop of 5% for the quarter leading to poor operating performance. With initial forecasts of favourable monsoon, we expect strong recovery in volumes for the company going forward. We expect the company to report revenue and earnings CAGR of 15% and 24.1% through FY16-18E and...
|